ARCHIVES

Duke Plans To Restart Three Trials Using Tumor Microarray Analysis

This article is from The Cancer Letter archive.

Vol. 36 No. 03 | January 29, 2010

Download PDF Visit The Full Archive

Related Articles

MD Anderson Completes $500 Million Research Endowment

September 24, 2010

Is More Better? ASCO Plenary Session Opens Debate On High-Dose Chemotherapy

May 28, 1999

FDA: Oncology Division Director Delap Promoted In Agency

May 29, 1998

New Breast Cancer Trials to Include Pre Vs. Post Operative Chemotherapy, CSF Pilot Studies

August 5, 1988

Combined analysis moves Herceptin to adjuvant setting in breast cancer.

May 27, 2005

In Brief: Clinical Education Program to Be Phased Out; Ken Endicott Retires From Grupenhoff Firm

January 31, 1986